Publication | Open Access

4-Deoxyphorbol inhibits HIV-1 infection in synergism with antiretroviral drugs and reactivates viral reservoirs through PKC/MEK activation synergizing with vorinostat

Antiretroviral DrugsMedicineImmunologyAntiviral ResponseAntiviral TherapyPharmacotherapyPkc/mek ActivationAntiviral DrugViral ReservoirsHivPharmacologyAntiviral Compound